CSPC Pharmaceutical Group Ltd (1093)

Get an in-depth profile of CSPC Pharmaceutical Group Ltd, including a general overview of the company's business and key management, as well as employee data and location and contact information.

0.9132 -0.0378 (-3.97%)

08:01:00 Delayed Data EUR Disclaimer

CSPC Pharmaceutical Group Ltd Company Profile

Industry: Pharmaceuticals
Sector: Healthcare
Employees: 24746
Equity Type: ORD

CSPC Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical products in the People’s Republic of China, other Asian regions, the Americas, Europe, and internationally. The company operates through Finished Drugs, Bulk Products, and Functional Food and Others segments. It provides NBP soft capsules and injections for acute ischemic stroke; Oulaining capsules and injections to treat mild to moderate memory and mental impairment; Enxi to treat adult idiopathic Parkinson’s disease; Duomeisu for lymphoma, multiple myeloma, ovarian and breast cancers, and other malignant tumors; Jinyouli to prevent leucopenia and infection induced by chemotherapy; and Keaili for breast cancer. The company also offers Shuluoke, Nuomoling, Weihong, and Xinweihong for various infections; Xuanning for hypertension; Encun to prevent atherosclerotic thrombosis events; Qixiao to treat upper respiratory tract infection; Linmeixin and Shuanglexin for diabetes; Gubang and Gubangjia to treat osteoporosis in postmenopausal women; and Gaoshunsong for arthritis, osteoarthritis, ankylosing spondylitis, frozen shoulder, bursuitis, tenosynovitis, acute gout, dysmenorrhea, toothache and postoperative pain, low back pain, sprain, strain, and other soft tissue injuries. In addition, it provides Debixin for various ulcer; Qimaite for acute and chronic pains; antibiotics, vitamin C, and caffeine APIs; functional food and glucose products; and healthcare services. The company was formerly known as China Pharmaceutical Group Limited and changed its name to CSPC Pharmaceutical Group Limited in March 2013. CSPC Pharmaceutical Group Limited was incorporated in 1992 and is headquartered in Shijiazhuang, the People’s Republic of China.

Contact Information

Address: Shijiazhuang,050035 China
Phone: 86 31 1870 37015
Fax: 86 31 1870 39608
Web: https://www.cspc.com.hk

Top Executives

Name	Age	Since	Title
Chuan Chen	57	2016	Independent Non-Executive Director
Qingxi Wang	55	2018	Executive Director
Hongguang Wang	58	2021	Independent Non-Executive Director
Chun Kwok Au	48	2021	Independent Non-Executive Director
Bo Wang	61	2012	Independent Non-Executive Director
Cheuk Kin Law	59	2021	Independent Non-Executive Director
Hao Jiang	38	2020	Executive Director
Weidong Pan	52	2006	Executive Director
Kin Man Chak	56	2005	Executive Director
Zhenguo Wang	52	2012	Executive Director
Huaiyu Wang	59	2010	Executive Director
Chunlei Li	46	2017	Executive Director & Chief Scientist
Dongchen Cai	68	1997	Executive Chairman
Cuilong Zhang	53	2018	Vice-Chairman & CEO
Guizhen Wu	62	2022	Independent Non-Executive Director

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.